18+ • For Research & Educational Purposes Only • Not Medical Advice  Disclaimer
Peptide Wiki
LongevityPhase 2

SS-31 (Elamipretide)

Mitochondria-targeted tetrapeptide that reduces oxidative stress and restores ATP production at the inner mitochondrial membrane

Research Reality Check

Worth WatchingThere is a real signal, but it is not settled.
ClaimSome people claim SS-31 (Elamipretide) has clear value for longevity research.
RealityThere is a real research signal, but important questions remain.
Bottom LineUse the evidence score, sources, and safety notes before taking any claim seriously.
Why People Believe ThisSimple explanations and user stories can sound more certain than the research is.
Watch Out For
Guaranteed resultsExact protocols presented as provenAnecdotes used as proof
143Discussions
2Citations

Evidence Dossier

79Evidence

Phase 2

Evidence score reflects source depth, citations, and research maturity. It is not a medical recommendation.

2Citations
143Discussions
Start Here

SS-31 (Elamipretide) at a glance

A fast read for beginners, with evidence strength, route context, safety depth, and community activity surfaced before the deeper sections.

Evidence score79Phase 2 human research
Primary routeSubcutaneous InjectionRoute availability varies by context
Safety depthLimited dataReview safety notes before making assumptions
Community questions143Related discussions and experiences

SS-31 (Szeto-Schiller peptide 31, also known as Elamipretide) is a synthetic aromatic-cationic tetrapeptide that selectively concentrates in the inner mitochondrial membrane. Developed by Hazel Szeto and Peter Schiller, it interacts with cardiolipin - a unique phospholipid critical for mitochondrial membrane structure and the electron transport chain.

How It Works

By stabilizing cardiolipin and the proteins associated with it (including cytochrome c and the electron transport chain complexes), SS-31 reduces mitochondrial reactive oxygen species (ROS) production, restores ATP synthesis efficiency, and prevents cytochrome c from functioning as a peroxidase - a damaging role it assumes when cardiolipin is oxidized.

SS-31 has produced striking results across a broad range of disease models including heart failure, renal disease, neurodegenerative conditions, and aging. It is among the very few compounds demonstrated to meaningfully improve mitochondrial function in aged tissue and is in clinical trials for heart failure with preserved ejection fraction (HFpEF).

Key Benefits

✓
Mitochondrial membrane stabilization
✓
Restored ATP production
✓
Reduced oxidative stress and ROS
✓
Cardioprotection
✓
Anti-aging cellular energy restoration

Saves this peptide to your Watchlist and helps you find new research, news, and questions later.

Quick Dosing Reference
Dose Range1-5mg
FrequencyOnce daily
RouteSubQ injection
Experience LevelBeginner